Reuters reported that isotope maker Nordion’s future is uncertain, as they examine alternatives.

As quoted in the market report:

Nordion is one of the world’s leading producers of molybdenum-99, which is used in medical imaging, and it depends on raw material from AECL’s ageing facility in Chalk River, Ontario. The plant has been operating since 1957, and while it is licensed to operate until 2016, its future beyond that is unclear.

To view the whole Reuters report, click here.